13F HOLDINGS REPORT
BROADWOOD CAPITAL INC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0000919574-23-003205
Total Value
$1.42B
Positions
7
Other Managers
1
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | STAAR SURGICAL CO | STAA | 8,783,082 | $561.7M | 39.52% |
| 2 | MONSTER BEVERAGE CORP NEW | MNST | 9,312,976 | $503.0M | 35.39% |
| 3 | AXON ENTERPRISE INC | AXON | 760,062 | $170.9M | 12.02% |
| 4 | ISHARES TR | 464287655 | 690,000 | $123.1M | 8.66% |
| 5 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 34,935,485 | $52.4M | 3.69% |
| 6 | ONCOCYTE CORP | 68235C107 | 23,353,697 | $8.3M | 0.58% |
| 7 | AGEX THERAPEUTICS INC | 00848H108 | 2,997,156 | $2.0M | 0.14% |